Dr. Daphna Laifenfeld Speaks at PMWC 2022

NeuroKaire (formerly Genetika+) personalizes treatment in the mental health space, initially focusing on depression. The NeuroKaire (formerly Genetika+) platform uses innovative technology to predict the best drug treatment for each patient, enabling faster treatment, fewer side effects, and lower dosing.

Dr. Daphna Laifenfled was one of the incredible lecturers at the Precision Medicine World Conference in Sillicon Valley. Dr. Laifenfeld spoke about our “brain-in-a-dish” platform, showcasing some of our exciting results for supporting drug development and optimizing treatment choice for those suffering from depression. Precision Medicine experts gathered from all over the world to discuss and learn about new initiatives going on in the world of personalized medicine.